News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros
News Boehringer's Humira biosimilar approved in EU AbbVie’s big-selling Humira will face competition from at least three biosimilars in Europe in around a year’s time, after the European Commission approved a biosimilar from Boehringer Inge
News China to accept overseas clinical trial data The Chinese government has announced plans to accept data from clinical trials carried out overseas, in order to speed up approvals.
News Bayer left playing catch-up with BMS after Xarelto failure BMS' rival anticoagulant takes commanding market lead.
News J&J hopes FDA cardio label will limit Invokana damage Diabetes drug has been hit by amputation warning on label.
News More data supports Jardiance lead in cardiovascular battle Cardioprotective effect occurred in patients independently of blood sugar control
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
